Cargando…

High sdLDL Cholesterol can be Used to Reclassify Individuals with Low Cardiovascular Risk for Early Intervention: Findings from the Chinese Multi-Provincial Cohort Study

Aim: A high-risk strategy has been implemented for lipid-lowering therapy in the primary prevention of cardiovascular disease. However, atherosclerosis and cardiovascular events are common among individuals with low cardiovascular risk. This study aimed to determine whether the small dense low-densi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yue, Liu, Jing, Wang, Wei, Wang, Miao, Zhao, Fan, Sun, Jiayi, Liu, Jun, Deng, Qiuju, Zhao, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406409/ https://www.ncbi.nlm.nih.gov/pubmed/31666437 http://dx.doi.org/10.5551/jat.49841

Ejemplares similares

Cytokeratin 8 in Association with sdLDL and ELISA Development
por: Ashmaig, Mohmed
Publicado: (2015)

Precipitated sdLDL: An easy method to estimate LDL particle size
por: Fernández‐Cidón, Bárbara, et al.
Publicado: (2020)

Serum sdLDL-C and Cellular SREBP2-dependent Cholesterol Levels; is there a Challenge on Targeting PCSK9?
por: Soltanmohammadi, Elham, et al.
Publicado: (2016)

Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Comparison of seven different reagents of peroxidase method for small and dense low density lipoprotein cholesterol (sdLDL‐C) measurement
por: Xuesong, Fan, et al.
Publicado: (2020)

Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma
por: Guo, Yi, et al.
Publicado: (2021)

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy
por: Tian, Yong, et al.
Publicado: (2021)

PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment
por: Liu, Yan, et al.
Publicado: (2019)

Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation
por: Izumida, Toshihide, et al.
Publicado: (2020)

Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study
por: Sorokin, Alexander V., et al.
Publicado: (2023)

Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C
por: Li, Sha, et al.
Publicado: (2016)

Investigation of galectin-3, lipocalin 2, retinol binding protein (RBP), small dense low-density lipoprotein (sdLDL) in patients with hirsutism
por: Yavuz, Ibrahim Halil, et al.
Publicado: (2019)

Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years
por: Chen, Yanhong, et al.
Publicado: (2022)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

Association of apolipoprotein Cs with new-onset type 2 diabetes mellitus: findings from the Chinese multi-provincial cohort study
por: Li, Jiangtao, et al.
Publicado: (2021)

Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study
por: Li, Jiangtao, et al.
Publicado: (2022)

Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study
por: Li, Jiangtao, et al.
Publicado: (2022)

Reclassifying stroke lesion anatomy
por: Bonkhoff, Anna K., et al.
Publicado: (2021)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Codeine-containing medicines to be reclassified in NZ
Publicado: (2020)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
por: Wu, Zhiyuan, et al.
Publicado: (2023)

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
por: Chary, Abdolreza, et al.
Publicado: (2023)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012)

Need to reclassify keratocystic odontogenic tumor into cyst and neoplasm
por: Singh, Harkanwal Preet
Publicado: (2016)

How genomics reclassifies diseases: the case of Alport syndrome
por: Torra, Roser, et al.
Publicado: (2020)

Reclassifying contraceptives as over-the-counter medicines to improve access
por: Ammerdorffer, Anne, et al.
Publicado: (2022)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

The Identification of Metal Ion Ligand-Binding Residues by Adding the Reclassified Relative Solvent Accessibility
por: Hu, Xiuzhen, et al.
Publicado: (2020)

Association between cumulative blood pressure and long-term risk of cardiovascular disease: findings from the 26-year Chinese Multi-provincial Cohort Study-Beijing Project
por: Liu, Shuai, et al.
Publicado: (2021)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uec2ndm0irpoe7hkacpon8en1a